Results 141 to 150 of about 2,157 (194)
Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis.
JAMA NeurolMüller J, Sharmin S, Lorscheider J, Ozakbas S, Karabudak R, Horakova D, Weinstock-Guttman B, Shaygannejad V, Etemadifar M, Alroughani R, Patti F, Eichau S, Prat A, Lugaresi A, Tomassini V, Kermode AG, Amato MP, Turkoglu R, Altintas A, Buzzard K, Soysal A, van der Walt A, Butzkueven H, Blanco Y, Gerlach O, Khoury SJ, Barnett M, John N, Lechner-Scott J, Foschi M, Surcinelli A, van Pesch V, Prevost J, Sa MJ, Maimone D, D'hooghe M, Hughes S, Hodgkinson S, McGuigan C, Cartechini E, Taylor B, Spitaleri D, Slee M, McCombe P, Yamout B, Benkert P, Kuhle J, Kappos L, Roos I, Kalincik T, MSBase Study Group, Havrdova EK, Girard M, Duquette P, Fabis-Pedrini M, Carroll WM, Skibina O, Gouider R, Mrabet S, Ramo-Tello C, Solaro C, Habek M, Van Wijmeersch B, Ampapa R, Macdonell R, Oreja-Guevara C, de Gans K, Laureys G, Oh J, Garber J, Gray O, Agüera-Morales E, Sanchez-Menoyo JL, Castillo-Triviño T, Grigoriadis N, Petersen T, Hardy TA, Vucic S, Reddel S, Ramanathan S, Al-Asmi A, Simu M, Baghbanian SM, Poehlau D, Al-Harbi T, Rojas JI, Deri N, Lalive P, Cambron M, Csepany T, Shuey N, Willekens B, Shaw C, Decoo D, Massey J, Yaldizli Ö, Derfuss T, Granziera C. +97 moreeuropepmc +1 more sourcePersistence and emergence of new neuropsychological deficits following SARS-CoV-2 infection: A follow-up assessment of the Geneva COVID-COG cohort. [PDF]
J Glob HealthVoruz P, de Alcântara IJ, Nuber-Champier A, Cionca A, Guérin D, Allali G, Benzakour L, Lalive PH, Lövblad KO, Braillard O, Nencha U, Nehme M, Coen M, Serratrice J, Reny JL, Pugin J, Guessous I, Landis BN, Assal F, Péron JA. +19 moreeuropepmc +1 more sourceAssociation of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS. [PDF]
NeurologyCagol A, Benkert P, Melie-Garcia L, Schaedelin SA, Leber S, Tsagkas C, Barakovic M, Galbusera R, Lu PJ, Weigel M, Ruberte E, Radue EW, Yaldizli Ö, Oechtering J, Lorscheider J, D'Souza M, Fischer-Barnicol B, Müller S, Achtnichts L, Vehoff J, Disanto G, Findling O, Chan A, Salmen A, Pot C, Bridel C, Zecca C, Derfuss T, Derfuss T, Lieb JM, Remonda L, Wagner F, Vargas MI, Du Pasquier RA, Lalive PH, Pravatà E, Weber J, Cattin PC, Absinta M, Gobbi C, Leppert D, Kappos L, Kuhle J, Granziera C. +43 moreeuropepmc +1 more sourcePersonalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data. [PDF]
NPJ Digit MedPirmani A, De Brouwer E, Arany Á, Oldenhof M, Passemiers A, Faes A, Kalincik T, Ozakbas S, Gouider R, Willekens B, Horakova D, Havrdova EK, Patti F, Prat A, Lugaresi A, Tomassini V, Grammond P, Cartechini E, Roos I, Boz C, Alroughani R, Amato MP, Buzzard K, Lechner-Scott J, Guimarães J, Solaro C, Gerlach O, Soysal A, Kuhle J, Sanchez-Menoyo JL, Spitaleri D, Csepany T, Van Wijmeersch B, Ampapa R, Prevost J, Khoury SJ, Van Pesch V, John N, Maimone D, Weinstock-Guttman B, Laureys G, McCombe P, Blanco Y, Altintas A, Al-Asmi A, Garber J, Van der Walt A, Butzkueven H, de Gans K, Rozsa C, Taylor B, Al-Harbi T, Sas A, Rajda C, Gray O, Decoo D, Carroll WM, Kermode AG, Fabis-Pedrini M, Mason D, Perez-Sempere A, Simu M, Shuey N, Singhal B, Cauchi M, Hardy TA, Ramanathan S, Lalive P, Sirbu CA, Hughes S, Castillo Trivino T, Peeters LM, Moreau Y. +72 moreeuropepmc +1 more sourceComplement Activation Is Associated With Disease Severity in Multiple Sclerosis. [PDF]
Neurol Neuroimmunol NeuroinflammOechtering J, Stein K, Schaedelin SA, Maceski AM, Orleth A, Meier S, Willemse E, Qureshi F, Heijnen I, Regeniter A, Derfuss T, Benkert P, D'Souza M, Limberg M, Fischer-Barnicol B, Achtnichts L, Mueller S, Salmen A, Lalive PH, Bridel C, Pot C, Du Pasquier RA, Gobbi C, Wiendl H, Granziera C, Kappos L, Trendelenburg M, Leppert D, Lunemann JD, Kuhle J, Swiss MS Cohort Study. +30 moreeuropepmc +1 more source
